Search results
Novavax Stock May Soar 379%, According to Wall Street. Is the Stock a Buy Right Now?
Motley Fool via Yahoo Finance· 3 months agoNovavax (NASDAQ: NVAX) soared more than 2,700% early in the pandemic as investors bet on its ability...
FDA authorizes Novavax as new alternative to mRNA COVID-19 vaccines
CBS News via Yahoo News· 2 years agoThe Food and Drug Administration has granted Novavax's COVID-19 vaccine emergency use authorization,...
Is This the Telltale Sign to Sell Novavax Stock?
Motley Fool· 1 year agoUnfortunately, Novavax (NASDAQ: NVAX) hasn't had great timing. The company was late to the party in winning authorizations for its COVID-19 vaccine,...
Novavax Just Dropped a Bombshell on Investors: Even Management Is Questioning Its Future
Motley Fool· 1 year agoNovavax (NASDAQ: NVAX) faces an uncertain future ahead as the need for COVID-19 vaccines diminishes....
Better Recovery Story Buy: Novavax vs. Teladoc
Motley Fool via Yahoo Finance· 3 months agoEverybody loves a good recovery story. You can get in on a promising company, with a potentially bright future ahead, but at a terrific price. And that...
Novavax's Revenue Could Fall Even More -- and It's Actually Good News
Motley Fool· 2 years agoPick your favorite of these adjectives, and it will definitely apply to Novavax's (NASDAQ: NVAX) second-quarter update. What's more, Novavax slashed its full-year revenue guidance. Unsurprisingly ...
What’s in the Novavax Vaccine? Experts Break It All Down
Prevention via Yahoo News· 2 years agoThe Food and Drug Administration has authorized Novavax’s COVID-19 vaccine for use in the U.S....
Does This Message From Moderna Mean Bad News for Novavax?
Motley Fool· 7 months agoModerna (NASDAQ: MRNA) recently gave an update on its pipeline and future goals, and the biotech had...
Novavax COVID vaccine, potential 4th option, approved by FDA panel
NY Daily News via AOL· 2 years agoThe Novavax vaccine was 90% effective in clinical trials, but those tests were done in early 2021,...
Better Buy: Novavax or BioNTech Stock?
Motley Fool· 1 year agoLast week, the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the Food and Drug Administration (FDA) recommended a move toward a...
